Evidence map›Paper›PMID 35630998›Full record

ArticleNanomaterials (Basel, Switzerland)2022

In-Situ Fabricating V

Wentao Xu, Guoqiang Shu, Shihui Zhang, Lei Song, Kui Ma, Hairong Yue

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wentao XuLow-Carbon Technology and Chemical Reaction Engineering Laboratory, School of Chemical Engineering, Sichuan University, Chengdu 610065, China.
Guoqiang ShuLow-Carbon Technology and Chemical Reaction Engineering Laboratory, School of Chemical Engineering, Sichuan University, Chengdu 610065, China.
Shihui ZhangLow-Carbon Technology and Chemical Reaction Engineering Laboratory, School of Chemical Engineering, Sichuan University, Chengdu 610065, China.
Lei SongLow-Carbon Technology and Chemical Reaction Engineering Laboratory, School of Chemical Engineering, Sichuan University, Chengdu 610065, China.
Kui MaLow-Carbon Technology and Chemical Reaction Engineering Laboratory, School of Chemical Engineering, Sichuan University, Chengdu 610065, China.ORCID 0000-0002-5667-4755
Hairong YueLow-Carbon Technology and Chemical Reaction Engineering Laboratory, School of Chemical Engineering, Sichuan University, Chengdu 610065, China.

Funding

China Postdoctoral Science Foundation 2021M702326China Postdoctoral Science Foundation 2021TQ0220National Natural Science Foundation of China 22008160National Natural Science Foundation of China 22078208
6 · The paper itself

Abstract

Titanium dioxide is a mainstream photocatalyst, but it still confronts great obstacles of poor visible light absorption and rapid recombination rate of photogenerated carriers. Herein, we describe the design of a highly active visible-light photocatalytic system of graphited carbon layers anchored V2O5/TiO2 heterojunctions derived from Ti3C2 MXene, which demonstrates about 4.58 and 2.79 times higher degradation activity of MB under visible light (λ > 420 nm) than pure V2O5 and TiO2-carbon. Combined with the characterization results, the formed V2O5/TiO2 heterojunction promotes the separation of photogenerated carriers, while the graphitized carbon derived from MXene acts as an electronic reservoir to enhance the absorption of visible light. The ESR results show that superoxide radicals and hydroxyl radicals are the main active species in the reaction system. Therefore, we propose a possible mechanism model to provide a feasible idea for the subsequent design of high-efficiency photocatalysts for environmental treatment.

Indexed as

degradationheterojunctionMXenephotocatalysisvisible light

Identifiers

PMID35630998
PMCPMC9147991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.